Design, synthesis and evaluation of pyrazolopyrimidinone derivatives as novel PDE9A inhibitors for treatment of Alzheimer?s disease

被引：8

作者：

Zhang, Pei ^{[1
]}

Jiang, Mei-Yan ^{[1
]}

Le, Mei-Ling ^{[1
]}

Zhang, Bei ^{[1
]}

Zhou, Qian ^{[1
]}

Wu, Yinuo ^{[1
]}

Zhang, Chen ^{[1
]}

Luo, Hai-Bin ^{[1
]}

机构：

[1] Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangzhou 510006, Peoples R China

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2020年 / 30卷 / 14期

基金：

国家重点研发计划;

关键词：

SYNAPTIC PLASTICITY; PHOSPHODIESTERASE; 9; BAY; 73-6691; IN-VIVO; DISCOVERY; PF-04447943;

D O I：

10.1016/j.bmcl.2020.127254

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Phosphodiesterase-9 (PDE9) is a promising target for the treatment of Alzheimer's disease (AD). To discover efficient PDE9 inhibitors with good metabolic stability and solubility, a series of novel pyrazolopyrimidinone derivatives have been designed with the assistance of molecular docking and dynamics simulations. All the fourteen synthesized compounds gave excellent inhibition ratio against PDE9 at 10 nM. Compound 1k with the IC50 of 2.0 nM against PDE9, showed good metabolic stability (t1/2 of 57 min) in the RLM as well as good solubility (195 mg/L). The analysis on binding modes of targeted compounds may provide insight for further structural modification. © 2020 Elsevier Ltd

引用

页数：6

共 50 条

[41] Design, synthesis and evaluation of novel ferulic acid derivatives as multitarget-directed ligands for the treatment of Alzheimer's disease
Lan, Jin-Shuai
Zeng, Rui-Feng
Jiang, Xiao-Yi
Hou, Jian-Wei
Liu, Yun
Hu, Zheng-Hao
Li, Hong-Xin
Li, Yin
Xie, Sai-Sai
Ding, Yue
Zhang, Tong
BIOORGANIC CHEMISTRY, 2020, 94
[42] Design and synthesis of novel curcumin derivatives as potent PDE4 inhibitors for the treatment of depression
Zhou, Haodong
Zhu, Yulan
Huang, Xianfeng
JOURNAL OF CHEMICAL RESEARCH, 2024, 48 (06)
[43] Novel PDE5 inhibitors derived from rutaecarpine for the treatment of Alzheimer's disease
Huang, Xian-Feng
Dong, Yan-Hua
Wang, Jin-Hui
Ke, Heng-Ming
Song, Guo-Qiang
Xu, De-Feng
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2020, 30 (09)
[44] Design and synthesis of a potent, selective, brain penetrate PDE9 inhibitor as a potential treatment for Alzheimer's disease
Kang, Zhijun
Helal, Christopher J.
Claffey, Michelle M.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 241
[45] Design, Synthesis, and Evaluation of Multitarget-Directed Resveratrol Derivatives for the Treatment of Alzheimer's Disease
Lu, Chuanjun
Guo, Yueyan
Yan, Jun
Luo, Zonghua
Luo, Hai-Bin
Yan, Ming
Huang, Ling
Li, Xingshu
JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (14) : 5843 - 5859
[46] Design, Synthesis and Biological Evaluation of Nobiletin Derivatives as Multifunctional Agents for the Treatment of Alzheimer's Disease
Zhou, Licheng
Shi, Ximeng
Yin, Huanhuan
Huang, Yi
Wang, Rui
Ma, Lei
CHEMISTRYSELECT, 2021, 6 (04): : 569 - 575
[47] Design, synthesis, and biological evaluation of novel N-Benzyl piperidine derivatives as potent HDAC/AChE inhibitors for Alzheimer's disease
Qin, Pengxia
Ran, Yingying
Xie, Fei
Liu, Yujing
Wei, Chao
Luan, Xiaoyi
Wu, Jingde
BIOORGANIC & MEDICINAL CHEMISTRY, 2023, 80
[48] Design, synthesis and biological evaluation of novel benzoxaborole derivatives as potent PDE4 inhibitors for topical treatment of atopic dermatitis
Chu, Zhaoxing
Xu, Qinlong
Zhu, Qihua
Ma, Xiaodong
Mo, Jiajia
Lin, Gaofeng
Zhao, Yan
Gu, Yuanfeng
Bian, Lincui
Shao, Li
Guo, Jing
Ye, Wenfeng
Li, Jiaming
He, Guangwei
Xu, Yungen
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 213
[49] Design, Synthesis, and Evaluation of Novel Ferulic Acid Derivatives as Multi-Target-Directed Ligands for the Treatment of Alzheimer's Disease
Sang, Zhipei
Wang, Keren
Han, Xue
Cao, Mengxiao
Tan, Zhenghuai
Liu, Wenmin
ACS CHEMICAL NEUROSCIENCE, 2019, 10 (02): : 1008 - 1024
[50] Novel deoxyvasicinone derivatives as potent multitarget-directed ligands for the treatment of Alzheimer's disease: Design, synthesis, and biological evaluation
Ma, Fang
Du, Hongtao
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 140 : 118 - 127

← 1 2 3 4 5 →